Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 521 entries
View as:

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00717678 Org: User:
Start: 12/31/07 End: 04/30/10 Due: 04/30/11

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

Phase: N/A Priority: Normal
NCT ID: NCT00720408 Org: User:
Start: 12/31/07 End: 09/30/09 Due: 09/30/10

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

Phase: N/A Priority: Normal
NCT ID: NCT01364974 Org: User:
Start: 01/31/09 End: 05/31/09 Due: 05/31/10

Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01908296 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT02038868 Org: User:
Start: 07/22/13 End: 04/04/14 Due: 04/04/15

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00667056 Org: User:
Start: 07/31/04 End: 12/31/04 Due: 12/31/05

Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01872026 Org: User:
Start: 12/26/12 End: 06/26/13 Due: 06/26/14

A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01284920 Org: User:
Start: 11/02/10 End: 07/02/14 Due: 07/02/15

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00643071 Org: User:
Start: 09/30/06 End: 05/31/08 Due: 05/31/09

Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02181660 Org: User:
Start: 06/16/14 End: 06/27/16 Due: 06/27/17

A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

Phase: N/A Priority: Normal
NCT ID: NCT00044057 Org: User:
Start: 12/31/00 End: 01/31/03 Due: 01/31/04

Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

Phase: N/A Priority: Normal
NCT ID: NCT00321113 Org: User:
Start: 09/30/04 End: 03/31/08 Due: 03/31/09

Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00281554 Org: User:
Start: 10/31/05 End: 01/31/07 Due: 01/31/08

Community Based Trial for AMEVIVE®

Phase: N/A Priority: Normal
NCT ID: NCT00168753 Org: User:
Start: 07/31/04 End: 03/31/05 Due: 03/31/06

To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.

Phase: N/A Priority: Normal
NCT ID: NCT00296361 Org: User:
Start: 10/31/04 End: 07/31/06 Due: 07/31/07

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00666159 Org: User:
Start: 12/31/02 End: 05/31/03 Due: 05/31/04

A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01279915 Org: User:
Start: 10/31/10 End: 01/31/11 Due: 01/31/12

A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01476800 Org: User:
Start: 07/31/06 End: 11/30/06 Due: 11/30/07

A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02133404 Org: User:
Start: 03/14/14 End: 11/10/14 Due: 11/10/15

A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01649999 Org: User:
Start: 03/01/12 End: 07/20/13 Due: 07/20/14

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01742611 Org: User:
Start: 03/31/13 End: 04/30/15 Due: 04/30/16

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00913120 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00816686 Org: User:
Start: 10/31/08 End: 04/30/10 Due: 04/30/11

A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)

Phase: N/A Priority: Normal
NCT ID: NCT00337558 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01016054 Org: User:
Start: 10/31/09 End: 04/30/10 Due: 04/30/11